TABLE 1.

Outcomes in 51 patients with SSMs

Outcome	Value (%)
Radiographic EOR*
GTR (100%)	40/47 (85.1)
NTR (95–99%)	6/47 (12.8)
STR (<95%)	1/47 (2.1)
Progression or recurrence	9/51 (17.6)
Recurrence after GTR	1/37 (2.7)
Progression after NTR	4/9 (44.4)†
Progression after STR	4/5 (80.0)‡
Management
Radiation	4
Craniotomy	3
Monitoring	2
Median follow-up in mos, range	35.0, 0–132
Postop visual outcome
Improved (preop deficit)	31/46 (67.4)§
Stable (preop deficit)	12/46 (26.1)§
Worse (all pts)	3/51 (5.9)
Adverse events
CSF leak	5 (9.8)
Infection	6 (11.8)
Long-term pituitary dysfunction¶
Anterior	2/49 (4.1)
Posterior	0/49 (0)
Vascular injury	1 (2)

pts = patients.

^*Radiographic EOR among patients in whom GTR was the surgical goal.

^†For purposes of the analysis identifying predictors of EOR, NTR includes 3 cases in which there was a radiographic GTR but the surgeon prospectively noted a small intraoperative residual (6 + 3 = 9).

^‡For purposes of the analysis identifying predictors of EOR, STR includes 4 patients in whom GTR was not the surgical goal (1 + 4 = 5).

^§Among patients with a preoperative visual deficit and postoperative follow-up.

^¶Two patients had preoperative pituitary dysfunction in multiple axes, one of whom experienced improvement postoperatively.